4,968
Views
21
CrossRef citations to date
0
Altmetric
Editorial

The Emerging Field of Senotherapeutic Drugs

Pages 2369-2372 | Received 11 Jun 2018, Accepted 08 Aug 2018, Published online: 16 Oct 2018
 
View correction statement:
The emerging field of senotherapeutic drugs

Acknowledgements

The author would like to thank the editors of the journal for their kind invitation and E Mikros for his critical reading of this manuscript.

Financial & competing interests disclosure

The author acknowledges financial support by the H2020-INFRADEV-01-2017 project EPTRI (777554). The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.